Advancing evidence-generating medicine
Osmind’s research is helping to set new standards for mental health interventions and improve patient outcomes. See how we work with research partners to generate real-world evidence to accelerate advances in mental health care.
Selected research projects
Novel strategies for ABI neurorehabilitation and neurobehavioral recovery
O'Shanick, G., & Sauvé, W. (2026). Neuromodulation: Novel strategies for ABI neurorehabilitation and neurobehavioral recovery. Interactive workshop presented at the North American Brain Injury Society (NABIS) 18th Annual Conference on Brain Injury, March 2026.
Psilocybin services and mental health outcomes within Oregon’s state-regulated model
Gow, A., Shih, E., Reid, R., Qian, J. J., Mellor, C., McInnes, L. A., Carhart-Harris, R., & Davis, J. N. (2026). Psilocybin services and mental health outcomes within Oregon's state-regulated model. *medRxiv* 2026.
Osmind Supports Successful FDA Type C Meeting in Support of New Drug Application
Osmind partners with LivaNova to Support Education and Awareness for Clinicians Caring for People Living with Difficult-to-treat Depression
Ketamine Infusion Therapy for PTSD: Real World Outcomes in over 8,000 patients
McInnes, L. A., Berman, R. M., & Shih, E. (2026). Ketamine infusion therapy for PTSD: Real-world outcomes in over 8,000 patients. Symposium presentation at the ASKP Annual Meeting, January 2026.
Osmind provides regulatory-grade RWE in support of New Drug Application
Let's transform mental health together
Click here to learn more about our research or to discuss collaboration opportunities.
